Design and synthesis of heterocyclic compounds for neuroprotective enzyme interactions / Louis H.A. Prins

Neurodegenerative diseases are thought to be multifactorial in nature and therefore current research focus has shifted from a ‘one-drug-one-target’ approach to that of multitarget directed ligands (MTDLs). These ligands are designed to address more than one etiological target, thereby increasing pat...

Full description

Bibliographic Details
Main Author: Prins, Louis Hendrik Albertus
Language:en
Published: North-West University 2011
Online Access:http://hdl.handle.net/10394/4230
id ndltd-NWUBOLOKA1-oai-dspace.nwu.ac.za-10394-4230
record_format oai_dc
spelling ndltd-NWUBOLOKA1-oai-dspace.nwu.ac.za-10394-42302014-04-16T03:56:11ZDesign and synthesis of heterocyclic compounds for neuroprotective enzyme interactions / Louis H.A. PrinsPrins, Louis Hendrik AlbertusNeurodegenerative diseases are thought to be multifactorial in nature and therefore current research focus has shifted from a ‘one-drug-one-target’ approach to that of multitarget directed ligands (MTDLs). These ligands are designed to address more than one etiological target, thereby increasing patient compliance and decreasing side-effects. Monoamine oxidase (MAO) and nitric oxide synthase (NOS) are enzymes that have long been associated with neurodegenerative diseases. MAO-B is responsible for the metabolism of biogenic amines, including dopamine. During this process hydrogen peroxide (H2O2) is formed leading to the production of highly reactive hydroxyl radicals (·OH), in the presence of free iron cations (Fe2+, Fe3+). NOS is responsible for the oxidation of L-arginine to L-citrulline and NO. Since NO is a free radical, an overproduction thereof by neuronal NOS (nNOS) may cause oxidative damage to neuronal cells in the substantia nigra, linking it to the development of Parkinson’s disease (PD). The selective inhibition of MAO-B and nNOS is therefore hypothesised to be advantageous for the treatment and prevention of neurodegeneration. The aim of this study was therefore to synthesise a series of selective MAO-B inhibitors and to determine if they also exhibit NOS inhibitory activity. Three series of compounds were synthesised comprising pteridine-2,4-diones, benzofuranes and indoles. The pteridine-2,4-diones were obtained by reacting 1,3- dimethyl-5,6-diaminouracil with the appropriate aldehyde to yield the pyrimidines, which were cyclicised by the addition of triethyl orthoformate to obtain the final products. For the benzofuranes activation chemistry using dicyclohexylcarbodiimide (DCC) was applied to conjugate the appropriate benzoic or cinnamic acid with 5-hydroxy-3Hbenzofuran- 2-one, producing the final products. The indole derivatives were synthesised by conjugating 5-amino-2-methylindole to the appropriate benzoic or cinnamic acid in the presence of either N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC.HCl) or DCC.Thesis (Ph.D. (Pharmaceutical Chemistry))--North-West University, Potchefstroom Campus, 2010.North-West University2011-06-30T12:34:39Z2011-06-30T12:34:39Z2010Thesishttp://hdl.handle.net/10394/4230en
collection NDLTD
language en
sources NDLTD
description Neurodegenerative diseases are thought to be multifactorial in nature and therefore current research focus has shifted from a ‘one-drug-one-target’ approach to that of multitarget directed ligands (MTDLs). These ligands are designed to address more than one etiological target, thereby increasing patient compliance and decreasing side-effects. Monoamine oxidase (MAO) and nitric oxide synthase (NOS) are enzymes that have long been associated with neurodegenerative diseases. MAO-B is responsible for the metabolism of biogenic amines, including dopamine. During this process hydrogen peroxide (H2O2) is formed leading to the production of highly reactive hydroxyl radicals (·OH), in the presence of free iron cations (Fe2+, Fe3+). NOS is responsible for the oxidation of L-arginine to L-citrulline and NO. Since NO is a free radical, an overproduction thereof by neuronal NOS (nNOS) may cause oxidative damage to neuronal cells in the substantia nigra, linking it to the development of Parkinson’s disease (PD). The selective inhibition of MAO-B and nNOS is therefore hypothesised to be advantageous for the treatment and prevention of neurodegeneration. The aim of this study was therefore to synthesise a series of selective MAO-B inhibitors and to determine if they also exhibit NOS inhibitory activity. Three series of compounds were synthesised comprising pteridine-2,4-diones, benzofuranes and indoles. The pteridine-2,4-diones were obtained by reacting 1,3- dimethyl-5,6-diaminouracil with the appropriate aldehyde to yield the pyrimidines, which were cyclicised by the addition of triethyl orthoformate to obtain the final products. For the benzofuranes activation chemistry using dicyclohexylcarbodiimide (DCC) was applied to conjugate the appropriate benzoic or cinnamic acid with 5-hydroxy-3Hbenzofuran- 2-one, producing the final products. The indole derivatives were synthesised by conjugating 5-amino-2-methylindole to the appropriate benzoic or cinnamic acid in the presence of either N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC.HCl) or DCC. === Thesis (Ph.D. (Pharmaceutical Chemistry))--North-West University, Potchefstroom Campus, 2010.
author Prins, Louis Hendrik Albertus
spellingShingle Prins, Louis Hendrik Albertus
Design and synthesis of heterocyclic compounds for neuroprotective enzyme interactions / Louis H.A. Prins
author_facet Prins, Louis Hendrik Albertus
author_sort Prins, Louis Hendrik Albertus
title Design and synthesis of heterocyclic compounds for neuroprotective enzyme interactions / Louis H.A. Prins
title_short Design and synthesis of heterocyclic compounds for neuroprotective enzyme interactions / Louis H.A. Prins
title_full Design and synthesis of heterocyclic compounds for neuroprotective enzyme interactions / Louis H.A. Prins
title_fullStr Design and synthesis of heterocyclic compounds for neuroprotective enzyme interactions / Louis H.A. Prins
title_full_unstemmed Design and synthesis of heterocyclic compounds for neuroprotective enzyme interactions / Louis H.A. Prins
title_sort design and synthesis of heterocyclic compounds for neuroprotective enzyme interactions / louis h.a. prins
publisher North-West University
publishDate 2011
url http://hdl.handle.net/10394/4230
work_keys_str_mv AT prinslouishendrikalbertus designandsynthesisofheterocycliccompoundsforneuroprotectiveenzymeinteractionslouishaprins
_version_ 1716665009882267648